Urol Oncol. 2009 Jan-Feb;27(1):67-71.

Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?

Klein EA, Ciezki J, Kupelian PA, Mahadevan A.

Source

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. KLEINE@ccf.org

Abstract

The treatment of localized prostate cancer remains controversial because of the lack of conclusive well-controlled or randomized studies comparing outcome of various forms of radiotherapy (RT) to radical prostatectomy (RP). We review recent results from an institutional database and prospective quality of life study comparing cancer-related and quality of live (QOL) outcomes among different treatment modalities for intermediate risk prostate cancer. The results suggest similar short-term survival but domain-specific effects on QOL after treatment with radical prostatectomy, brachytherapy, or external beam radiotherapy.

PMID:: 19111801; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification. [Asian J Androl. 2009]
Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.
Takizawa I, Hara N, Nishiyama T, Kaneko M, Hoshii T, Tsuchida E, Takahashi K. Asian J Androl. 2009 May; 11(3):283-90. Epub 2009 Apr 6.
Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. [J Urol. 2008]
Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM, Porter MP, Soloway MS. J Urol. 2008 Nov; 180(5):2005-9; discussion 2009-10. Epub 2008 Sep 17.
Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. [Int J Radiat Oncol Biol Phys. ...]
Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, et al. Int J Radiat Oncol Biol Phys. 2008 Oct 1; 72(2):421-32. Epub 2008 Mar 5.
Review A systematic review of randomized trials in localized prostate cancer. [Can J Urol. 2004]
Review A systematic review of randomized trials in localized prostate cancer.
Alibhai SM, Klotz LH. Can J Urol. 2004 Feb; 11(1):2110-7.
Review Localized prostate cancer: radiation or surgery? [Urol Clin North Am. 2003]
Review Localized prostate cancer: radiation or surgery?
Klein EA, Kupelian PA. Urol Clin North Am. 2003 May; 30(2):315-30, ix.

See reviews... See all...

Cited by 5 PubMed Central articles

mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer. [Endocr Relat Cancer. 2012]
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer.
Schiewer MJ, Den R, Hoang DT, Augello MA, Lawrence YR, Dicker AP, Knudsen KE. Endocr Relat Cancer. 2012 Feb; 19(1):1-12. Epub 2012 Jan 9.
Androgen receptor signaling in prostate cancer development and progression. [J Carcinog. 2011]
Androgen receptor signaling in prostate cancer development and progression.
Lonergan PE, Tindall DJ. J Carcinog. 2011; 10:20. Epub 2011 Aug 23.
Identification of a clinically relevant androgen-dependent gene signature in prostate cancer. [Cancer Res. 2011]
Identification of a clinically relevant androgen-dependent gene signature in prostate cancer.
Heemers HV, Schmidt LJ, Sun Z, Regan KM, Anderson SK, Duncan K, Wang D, Liu S, Ballman KV, Tindall DJ. Cancer Res. 2011 Mar 1; 71(5):1978-88. Epub 2011 Feb 15.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Outcomes for intermediate risk prostate cancer: are there advantages for surgery...
Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
Urol Oncol. 2009 Jan-Feb ;27(1):67-71.

PubMed
Obstetric fistulae in West Africa: patient perspectives.
Obstetric fistulae in West Africa: patient perspectives.
Am J Obstet Gynecol. 2009 May ;200(5):e40-2. Epub 2008 Dec 27 .

PubMed
Electrophysiological evidence of the adaptive task-set inhibition in task switch...
Electrophysiological evidence of the adaptive task-set inhibition in task switching.
Brain Res. 2009 Feb 19 ;1255:122-31. Epub 2008 Dec 16 .

PubMed
A library of yeast transcription factor motifs reveals a widespread function for...
A library of yeast transcription factor motifs reveals a widespread function for Rsc3 in targeting nucleosome exclusion at promoters.
Mol Cell. 2008 Dec 26 ;32(6):878-87.

PubMed
Perioperative red blood cell transfusion and outcome in stable patients after el...
Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery.
Eur J Vasc Endovasc Surg. 2009 Mar ;37(3):311-8. Epub 2008 Dec 25 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: